Company Overview of Behringwerke AG
Behringwerke AG develops and produces vaccines from animal and human blood plasma and body fluids. The company's products are used for treatment against allergies, asthma, rheumatic fever, and infectious diseases. Behringwerke was founded in 1904 and is based in Marburg, Germany.
Founded in 1904
49 64 21 39 0
49 64 21 39 39 86
Key Executives for Behringwerke AG
Behringwerke AG does not have any Key Executives recorded.
Similar Private Companies By Industry
|3B Pharmaceuticals GmbH||Europe|
|Accelsiors Group International||Europe|
|Aenova Group GmbH||Europe|
|Aenova Holding GmbH||Europe|
|AiCuris GmbH & Co. KG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Behringwerke AG, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.